Stockreport

Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update [TheStreet.com]

Intensity Therapeutics, Inc.  (INTS) 
PDF March 27, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the dis [Read more]